{"id":98246,"date":"2026-06-02T07:54:07","date_gmt":"2026-06-02T13:54:07","guid":{"rendered":"https:\/\/trimrx.com\/blog\/stopped-losing-weight-zepbound-plateau-explained\/"},"modified":"2026-06-02T07:54:07","modified_gmt":"2026-06-02T13:54:07","slug":"stopped-losing-weight-zepbound-plateau-explained","status":"publish","type":"post","link":"https:\/\/trimrx.com\/blog\/stopped-losing-weight-zepbound-plateau-explained\/","title":{"rendered":"Stopped Losing Weight on Zepbound? (Plateau Explained)"},"content":{"rendered":"<style>\n      .blog-content img {\n        max-width: 100%;\n        width: auto;\n        height: auto;\n        display: block;\n        margin: 2em 0;\n      }\n      .blog-content p {\n        font-size: 18px;\n        line-height: 1.8;\n        margin-bottom: 1.2em;\n        color: #333;\n      }\n      .blog-content ul, .blog-content ol {\n        font-size: 18px;\n        line-height: 1.8;\n        margin: 1.5em 0;\n      }\n      .blog-content li {\n        margin: 0.4em 0;\n      }\n      .blog-content h2 {\n        font-size: 24px;\n        font-weight: 600;\n        margin: 2em 0 0.8em 0;\n        color: #000;\n      }\n      .blog-content h3 {\n        font-size: 20px;\n        font-weight: 600;\n        margin: 1.5em 0 0.6em 0;\n        color: #000;\n      }\n      .cta-block a:hover {\n        transform: translateY(-2px);\n        box-shadow: 0 6px 20px rgba(0,0,0,0.3);\n      }<\/p>\n<\/style>\n<div class=\"blog-content\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Stopped Losing Weight on Zepbound? (Plateau Explained)<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Research from the SURMOUNT-1 trial showed that patients on tirzepatide (Zepbound) lost an average of 20.9% body weight over 72 weeks. But what the headlines rarely mention is that weight loss velocity wasn&#39;t linear. Most participants experienced at least one plateau lasting 3\u20136 weeks where the scale didn&#39;t move despite continuing medication. The reason has nothing to do with medication tolerance and everything to do with adaptive thermogenesis. Your body defending its new set point.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">We&#39;ve guided hundreds of patients through GLP-1 therapy protocols. The gap between breaking through a plateau and staying stuck comes down to three metabolic realities most people don&#39;t account for until they hit week twelve.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\"><strong style=\"font-weight: 700; color: inherit;\">Why Did I Stop Losing Weight on Zepbound?<\/strong><\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Weight plateaus on Zepbound occur when your total daily energy expenditure (TDEE) adapts to match your reduced caloric intake, eliminating the deficit that drove initial weight loss. Tirzepatide suppresses appetite and slows gastric emptying, but it doesn&#39;t override energy balance. Once your metabolism downregulates by 200\u2013400 calories per day through reduced NEAT (non-exercise activity thermogenesis) and adaptive thermogenesis, the medication&#39;s satiety effect maintains your new weight instead of continuing reduction. This typically happens 8\u201316 weeks into treatment when cumulative weight loss reaches 8\u201312% of starting body weight.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Blunt Truth: Zepbound Doesn&#39;t Stop Working \u2014 Your Deficit Does<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s the honest answer: if you stopped losing weight on Zepbound, the medication is still working exactly as designed. You&#39;re just no longer in a caloric deficit. Let&#39;s be direct about this: GLP-1 receptor agonists like tirzepatide reduce appetite, delay gastric emptying, and improve insulin sensitivity. What they don&#39;t do is magically burn fat independent of energy balance. When patients tell us &#39;the medication stopped working,&#39; what actually happened is their body adapted to the reduced intake, NEAT dropped by 15\u201325%, and they&#39;re now eating at their new maintenance level. The satiety signal is still there. The scale just isn&#39;t moving because thermodynamics caught up.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Why Metabolic Adaptation Stalls Weight Loss on GLP-1 Medications<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Metabolic adaptation is the primary mechanism behind weight plateaus on tirzepatide. When you lose 10\u201315 pounds, your body requires fewer calories to maintain basic functions. Basal metabolic rate decreases proportionally to lost lean mass, and NEAT (the calories burned through fidgeting, standing, and unconscious movement) drops significantly as your brain conserves energy. Research published in Obesity found that individuals who lost 10% body weight experienced a 20\u201325% reduction in NEAT compared to baseline. That&#39;s 300\u2013500 fewer calories burned daily without any conscious behaviour change.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Zepbound&#39;s appetite suppression keeps you eating less, but if &#39;less&#39; now equals your adapted TDEE, you&#39;re at equilibrium. The medication is functioning. Your caloric math just reset. This is why patients who report &#39;I&#39;m eating the same as week four&#39; are often stuck: what created a 500-calorie deficit at week four creates a zero-calorie deficit at week twelve after metabolic downregulation.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our experience shows that patients who track macros rather than just &#39;eating less&#39; identify this gap faster. The difference between 1,400 calories at week four (producing loss) and 1,400 calories at week fourteen (producing maintenance) is invisible without measurement, but the metabolic context has completely changed.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Three Factors That Determine Whether You Break Through or Stay Stuck<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Breaking a Zepbound plateau requires addressing one or more of these three variables: caloric intake, non-exercise activity thermogenesis, or lean mass preservation. Reducing intake by another 100\u2013200 calories per day re-establishes the deficit, but this approach has diminishing returns. Chronic restriction below 1,200\u20131,400 calories risks nutrient deficiency and further NEAT suppression. Increasing NEAT through deliberate movement. Walking an additional 3,000\u20135,000 steps daily, taking standing breaks every 90 minutes, using a treadmill desk. Adds 150\u2013300 calories of expenditure without triggering the compensatory appetite increase that formal exercise often causes on GLP-1 medications.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Lean mass preservation is the most overlooked factor. Every pound of muscle lost during weight reduction lowers your resting metabolic rate by approximately 6 calories per day. Lose ten pounds of muscle and your BMR drops 60 calories daily, compounding over months. Resistance training twice weekly and protein intake of 1.6\u20132.2 grams per kilogram body weight preserve muscle during fat loss, maintaining metabolic rate and making future deficits easier to sustain.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The mistake we see most often: patients assume the medication &#39;stopped working&#39; and either increase the dose prematurely or add cardio without adjusting intake. Dose escalation works if you&#39;re undertitrated (still experiencing hunger between meals), but if satiety is intact and the scale isn&#39;t moving, the issue is energy balance. Not receptor activation.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Zepbound Dosing vs Plateau: When to Titrate Up and When Not To<\/h2>\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Factor<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Titrate Dose Up<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Do Not Titrate. Address Deficit Instead<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Professional Assessment<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Hunger Between Meals<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Return of appetite 2\u20133 hours post-meal despite therapeutic dose<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Satiety intact through 6\u20138 hours post-meal<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">If you&#39;re genuinely hungry, higher dose may help; if satiety is solid, dose isn&#39;t the issue<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Current Dose vs Max<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">On 5mg or 7.5mg weekly with room to escalate<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Already at 10mg or 15mg weekly (max approved doses)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Escalation only works if undertitrated. Max dose can&#39;t override thermodynamics<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Weight Loss Velocity Before Plateau<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Lost less than 1% body weight per week during active loss phase<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Lost 1\u20132% body weight per week before plateau<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Slow initial loss suggests undertitration; normal velocity before plateau suggests adaptation<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">GI Side Effect History<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Minimal nausea, well-tolerated at current dose<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Significant nausea or vomiting at last titration<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Tolerance to current dose supports escalation if clinically indicated<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Time at Current Dose<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">4+ weeks at stable dose with no loss<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Titrated within last 2 weeks<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Allow 4 weeks per dose to assess true plateau vs temporary water retention<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Dietary Tracking<\/strong><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not tracking intake, unsure if in deficit<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Tracking macros, confirmed eating below calculated TDEE<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Untracked intake means you may not be in a deficit. Dose escalation won&#39;t fix that<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Dose escalation resets appetite suppression if tolerance has developed, but it doesn&#39;t create a deficit where none exists. The SURMOUNT-1 trial demonstrated that higher tirzepatide doses (10mg, 15mg) produced greater weight loss than 5mg, but the mechanism was increased satiety leading to lower intake. Not a metabolic rate increase. If you&#39;re already eating at a deficit and the scale isn&#39;t moving, increasing your dose won&#39;t change energy balance.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Key Takeaways<\/h2>\n<ul style=\"font-size: 18px; line-height: 1.8; margin: 1.5em 0; padding-left: 2.5em; list-style-type: disc;\">\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Weight plateaus on Zepbound occur when metabolic adaptation (200\u2013400 calorie TDEE reduction) eliminates the caloric deficit, not because the medication stops working<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">NEAT (non-exercise activity thermogenesis) drops 20\u201325% after 10% body weight loss, reducing daily expenditure by 300\u2013500 calories without conscious behaviour change<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Dose escalation helps if you&#39;re undertitrated (experiencing hunger), but won&#39;t break a plateau if satiety is intact and you&#39;re eating at maintenance<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Resistance training twice weekly and protein intake of 1.6\u20132.2g\/kg preserve lean mass, preventing the 6 calories\/day BMR drop per pound of muscle lost<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Tracking macros rather than &#39;eating less&#39; is the only way to confirm whether intake still creates a deficit after metabolic adaptation<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Increasing NEAT by 3,000\u20135,000 steps daily adds 150\u2013300 calories of expenditure without the compensatory appetite increase formal exercise triggers<\/li>\n<\/ul>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What If: Zepbound Plateau Scenarios<\/h2>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I Stopped Losing Weight After Three Months on Zepbound \u2014 Should I Increase My Dose?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Increase your dose only if you&#39;re experiencing return of appetite between meals. Genuine hunger 2\u20134 hours after eating signals undertitration. If satiety is intact (you&#39;re not hungry, just not losing), the issue is energy balance, not receptor activation. Before escalating, track intake for one week to confirm you&#39;re still in a deficit. Most patients at plateau are eating 100\u2013200 calories more than they realize, or their TDEE dropped and they&#39;re now at maintenance. Add 3,000 steps daily or reduce intake by 150\u2013200 calories for two weeks. If the scale moves, dose wasn&#39;t the problem.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I&#39;m at Maximum Zepbound Dose (15mg) and Still Plateaued?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">At maximum approved dose, further escalation isn&#39;t an option. You must address the deficit directly. Calculate your current TDEE using an adaptive TDEE calculator (track weight and intake for 10\u201314 days, adjust), then create a 300\u2013500 calorie deficit through reduced intake, increased NEAT, or both. Resistance training becomes critical here. Preserving lean mass maintains metabolic rate and prevents further adaptation. Consider a one-week diet break at maintenance calories to reverse some adaptive thermogenesis, then resume deficit. Maximum dose ensures optimal appetite suppression; it doesn&#39;t override thermodynamics.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I Stopped Losing Weight but I&#39;m Still Eating Very Little on Zepbound?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Define &#39;very little&#39; with numbers. Patients often overestimate restriction. If you&#39;re genuinely eating 1,200\u20131,400 calories and not losing, your TDEE adapted to match that intake. This is metabolic adaptation in action. Two options: increase expenditure (add 4,000\u20136,000 steps daily, resistance train 2\u20133\u00d7 weekly) or take a two-week diet break at maintenance to reverse adaptation before resuming deficit. Continuing to restrict below 1,200 calories risks nutrient deficiency, muscle loss, and further NEAT suppression. GLP-1 medications make low intake tolerable, but they don&#39;t prevent the metabolic consequences of chronic restriction.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Comparison Table: Plateau vs Undertitration \u2014 What&#39;s Actually Happening<\/h2>\n<div style=\"overflow-x:auto;-webkit-overflow-scrolling:touch;width:100%;margin:1.5em 0;\">\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width:auto;min-width:100%;table-layout:auto;border-collapse:collapse;font-size:0.95em;box-shadow:0 2px 4px rgba(0,0,0,0.1);\" style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color:#f8f9fa;border-bottom:2px solid #dee2e6;\" style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Indicator<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">True Plateau (Metabolic Adaptation)<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Undertitration (Dose Too Low)<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Next Action<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Hunger Pattern<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Satiety intact 6\u20138 hours post-meal<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Hunger returns 2\u20134 hours after eating<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Plateau: adjust deficit; Undertitration: escalate dose<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Weight Loss History<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Lost 1\u20132% body weight per week, then stopped<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Never achieved 1% weekly loss at any point<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Plateau: normal then stopped; Undertitration: slow from start<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Current Caloric Intake<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Eating 1,200\u20131,500 calories, tracked accurately<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Unknown intake, or eating 1,800\u20132,200+ calories<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Plateau: deficit disappeared; Undertitration: never established deficit<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Dose Level<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">At 7.5mg, 10mg, or 15mg weekly<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">At 2.5mg or 5mg weekly (early titration)<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Plateau: dose likely adequate; Undertitration: room to escalate<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Time Since Last Loss<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">3\u20136 weeks with no scale movement<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">6\u20138+ weeks with minimal or no loss<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Plateau: recent stall; Undertitration: chronic slow progress<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Honest Reality About Long-Term Weight Maintenance on GLP-1 Medications<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Most patients who reach goal weight on tirzepatide will need to continue the medication indefinitely to maintain loss. The SURMOUNT-1 extension data showed that participants who discontinued tirzepatide regained approximately two-thirds of lost weight within 52 weeks. This isn&#39;t medication failure. It reflects that GLP-1 agonists correct a physiological state (impaired satiety signaling, elevated ghrelin) that returns when the drug is removed. Plateaus during active treatment are temporary adaptation; the metabolic drive to regain is permanent without ongoing intervention.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our team has seen this pattern repeatedly: patients who view Zepbound as a tool for permanent metabolic management maintain results. Those who view it as a temporary weight loss course almost always regain. The medication works, but the biology that drove weight gain in the first place. Appetite dysregulation, insulin resistance, impaired incretin response. Doesn&#39;t resolve with weight loss alone.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">If cost, side effects, or personal preference make indefinite use unacceptable, transition planning with your prescriber is critical. Gradual dose reduction over 3\u20136 months, combined with established resistance training and protein-focused eating, gives you the best chance of maintaining 40\u201360% of lost weight off-medication. Expecting to maintain 100% of loss after stopping is unrealistic without extraordinary dietary discipline. And even then, metabolic adaptation works against you.<\/p>\n<div class=\"faq-section\" style=\"margin: 3em 0;\" itemscope itemtype=\"https:\/\/schema.org\/FAQPage\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 1em 0; color: #000;\">Frequently Asked Questions<\/h2>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Why did I stop losing weight on Zepbound after 3 months?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Weight loss plateaus after 8\u201316 weeks on Zepbound occur when your total daily energy expenditure adapts to match your reduced caloric intake, eliminating the deficit. Metabolic adaptation \u2014 including a 200\u2013400 calorie drop in NEAT and proportional BMR reduction from lost weight \u2014 means the same food intake that created a deficit at week four now maintains your new weight at week twelve. The medication is still suppressing appetite, but you&#8217;re no longer in energy deficit.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How do I break through a weight loss plateau on Zepbound?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Breaking a Zepbound plateau requires re-establishing a caloric deficit through one or more of these: reduce intake by 100\u2013200 calories daily, increase NEAT by adding 3,000\u20135,000 steps per day, or preserve lean mass through resistance training 2\u20133 times weekly with 1.6\u20132.2g protein per kg body weight. Track macros for one week to confirm current intake, calculate your adapted TDEE, then adjust. If satiety is intact and you&#8217;re undertitrated (still hungry between meals), dose escalation may help \u2014 otherwise, the issue is energy balance.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can I increase my Zepbound dose to restart weight loss?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Increasing your Zepbound dose helps restart weight loss if you&#8217;re undertitrated \u2014 experiencing return of appetite 2\u20134 hours after meals despite being on a therapeutic dose. If satiety is intact and you&#8217;re simply not losing weight, dose escalation won&#8217;t address the underlying issue: your caloric deficit disappeared due to metabolic adaptation. At maximum dose (15mg weekly), further escalation isn&#8217;t possible \u2014 you must adjust intake or expenditure directly.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What is the difference between a weight plateau and Zepbound tolerance?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">A weight plateau means your metabolism adapted to your reduced intake and you&#8217;re now eating at maintenance calories \u2014 the medication still suppresses appetite, but thermodynamics caught up. Tolerance would mean the GLP-1 receptor response diminished and hunger returned despite adequate dosing, which is rare with tirzepatide due to its long half-life and high receptor affinity. If you&#8217;re not hungry but not losing, it&#8217;s a plateau (energy balance issue). If you&#8217;re genuinely hungry between meals at therapeutic dose, consider undertitration or tolerance.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How much weight should I expect to lose per week on Zepbound?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">During active weight loss on Zepbound, expect 1\u20132% of body weight per week during the first 12\u201320 weeks at therapeutic dose (7.5mg\u201315mg weekly). A 200-pound patient would lose 2\u20134 pounds weekly initially, slowing to 0.5\u20131 pound weekly as they approach 15\u201320% total body weight reduction. The SURMOUNT-1 trial demonstrated mean weight loss of 20.9% over 72 weeks, but velocity wasn&#8217;t linear \u2014 most participants experienced at least one multi-week plateau.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Will I regain weight if I stop taking Zepbound?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Most patients regain 50\u201370% of lost weight within one year of discontinuing Zepbound, according to SURMOUNT-1 extension data. GLP-1 agonists correct impaired satiety signaling and elevated ghrelin \u2014 conditions that return when the medication is removed. Weight regain isn&#8217;t medication failure; it reflects that the underlying metabolic drivers of weight gain don&#8217;t resolve with weight loss alone. Long-term maintenance typically requires continued GLP-1 therapy or extraordinary dietary discipline with resistance training.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What is NEAT and why does it matter for Zepbound weight loss?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">NEAT (non-exercise activity thermogenesis) is the calories burned through unconscious movement \u2014 fidgeting, standing, walking, maintaining posture \u2014 and accounts for 15\u201330% of total daily energy expenditure. After 10% body weight loss, NEAT drops 20\u201325% (300\u2013500 calories daily) as your brain conserves energy, which eliminates the caloric deficit even if food intake stays constant. Deliberately increasing NEAT through 3,000\u20135,000 additional daily steps or frequent standing breaks counters this adaptation and restores deficit.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Should I add cardio or resistance training to break a Zepbound plateau?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Add resistance training, not cardio. Resistance training 2\u20133 times weekly preserves lean muscle mass during weight loss, preventing the 6 calories per day BMR drop per pound of muscle lost \u2014 this maintains metabolic rate and makes future deficits easier. Cardio burns calories during the session but often triggers compensatory appetite increase or NEAT reduction that negates the expenditure. If you add cardio, keep it low-intensity (walking, cycling) and track whether intake increases in response.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How do I know if I need a higher dose of Zepbound or just need to eat less?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">If you&#8217;re experiencing genuine hunger 2\u20134 hours after meals despite being on a therapeutic dose, you may be undertitrated and benefit from dose escalation. If satiety is intact \u2014 you&#8217;re not hungry, food just doesn&#8217;t appeal, you can go 6\u20138 hours without thinking about eating \u2014 the issue is energy balance, not dose. Track your intake for one week to confirm you&#8217;re actually in a deficit. Most plateaus at adequate dose are energy balance issues, not receptor activation failures.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What is adaptive thermogenesis and how does it affect Zepbound results?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Adaptive thermogenesis is your body&#8217;s metabolic downregulation in response to sustained caloric deficit \u2014 BMR decreases beyond what lost weight alone would predict, and NEAT drops significantly. Research shows a 20\u201325% reduction in NEAT after 10% weight loss, meaning a person maintaining 200 pounds after losing 20 pounds burns 300\u2013500 fewer calories daily than someone who always weighed 200 pounds. Zepbound doesn&#8217;t prevent this adaptation; it makes the reduced intake tolerable through appetite suppression. Breaking through requires adjusting for your new, lower TDEE.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can water retention cause a false plateau on Zepbound?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes \u2014 transient water retention from increased sodium intake, menstrual cycle fluctuations, or new exercise can mask fat loss for 1\u20133 weeks. If you&#8217;re in a confirmed deficit (tracking intake, calculating TDEE accurately) but the scale hasn&#8217;t moved for 10\u201314 days, wait another week before adjusting. True metabolic plateaus last 4+ weeks. Short-term stalls are usually water retention, hormonal shifts, or constipation (common on GLP-1 medications due to slowed gastric motility). Track weekly averages, not daily weigh-ins, to filter noise.<\/p>\n<\/div>\n<\/details>\n<style>.faq-item summary{outline:none;margin-bottom:0!important;padding-bottom:0!important;}.faq-item summary::-webkit-details-marker{display:none;}.faq-item[open] .faq-arrow{transform:rotate(180deg);}.faq-item>div{margin-top:0!important;padding-top:0!important;}.faq-item p{margin-top:0!important;}<\/style>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Weight plateaus on Zepbound occur when metabolic adaptation matches your new caloric baseline. We explain why it happens and what changes actually work.<\/p>\n","protected":false},"author":6,"featured_media":98245,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Stopped Losing Weight on Zepbound? (Plateau Explained)","_yoast_wpseo_metadesc":"Weight plateaus on Zepbound occur when metabolic adaptation matches your new caloric baseline. We explain why it happens and what changes actually work.","_yoast_wpseo_focuskw":"stopped losing weight zepbound","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[1],"tags":[],"class_list":["post-98246","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/98246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=98246"}],"version-history":[{"count":0,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/98246\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/98245"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=98246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=98246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=98246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}